ATE420626T1 - Verwendung eines porösen trägermaterials - Google Patents

Verwendung eines porösen trägermaterials

Info

Publication number
ATE420626T1
ATE420626T1 AT01958246T AT01958246T ATE420626T1 AT E420626 T1 ATE420626 T1 AT E420626T1 AT 01958246 T AT01958246 T AT 01958246T AT 01958246 T AT01958246 T AT 01958246T AT E420626 T1 ATE420626 T1 AT E420626T1
Authority
AT
Austria
Prior art keywords
support material
porous support
drug
loaded
controlled release
Prior art date
Application number
AT01958246T
Other languages
English (en)
Inventor
Rodney Sambrook
Wayne Austin
Mark Sambrook
Michael Hannon
Original Assignee
Dytech Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dytech Corp Ltd filed Critical Dytech Corp Ltd
Application granted granted Critical
Publication of ATE420626T1 publication Critical patent/ATE420626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Porous Artificial Stone Or Porous Ceramic Products (AREA)
  • Filtering Materials (AREA)
AT01958246T 2000-08-21 2001-08-21 Verwendung eines porösen trägermaterials ATE420626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020610.2A GB0020610D0 (en) 2000-08-21 2000-08-21 Uses of porous carriers

Publications (1)

Publication Number Publication Date
ATE420626T1 true ATE420626T1 (de) 2009-01-15

Family

ID=9898036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958246T ATE420626T1 (de) 2000-08-21 2001-08-21 Verwendung eines porösen trägermaterials

Country Status (17)

Country Link
US (1) US20040265350A1 (de)
EP (1) EP1311241B1 (de)
JP (1) JP2004506679A (de)
KR (1) KR20030040418A (de)
CN (1) CN1469736A (de)
AT (1) ATE420626T1 (de)
AU (2) AU7997001A (de)
BR (1) BR0113429A (de)
CA (1) CA2420194A1 (de)
DE (1) DE60137431D1 (de)
ES (1) ES2321479T3 (de)
GB (1) GB0020610D0 (de)
HU (1) HUP0303111A3 (de)
MX (1) MXPA03001546A (de)
PL (1) PL361056A1 (de)
RU (1) RU2283140C2 (de)
WO (1) WO2002015881A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
GB0311221D0 (en) * 2003-05-15 2003-06-18 Orthogem Ltd Biomaterial
JP2005060307A (ja) * 2003-08-12 2005-03-10 Pirumu:Kk 骨造成剤
US8529625B2 (en) 2003-08-22 2013-09-10 Smith & Nephew, Inc. Tissue repair and replacement
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP2007533643A (ja) * 2003-10-21 2007-11-22 サイメデイカ リミテツド 有機物質が含浸された多孔性半導体を含む複合材料
US7703983B2 (en) * 2004-06-10 2010-04-27 Ntn Corporation Sliding material and sliding bearing
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR100858699B1 (ko) * 2005-01-25 2008-09-17 주식회사 한불후치피아 동·식물성 식품의 가용성 성분을 유효성분으로 함유하는 식품 및 그 제조방법
WO2006133410A2 (en) * 2005-06-08 2006-12-14 Smaht Ceramics, Inc. Biocidal ceramic compositions, methods and articles of manufacture
KR20080084808A (ko) 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
US7939092B2 (en) 2006-02-01 2011-05-10 Warsaw Orthopedic, Inc. Cohesive osteogenic putty and materials therefor
US7824703B2 (en) 2006-02-01 2010-11-02 Warsaw Orthopedics, Inc. Medical implants with reservoir(s), and materials preparable from same
ES2427993T3 (es) 2006-02-09 2013-11-05 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
WO2007099697A1 (ja) * 2006-02-23 2007-09-07 University Corporation, Kanazawa Institute Of Technology 超伝導磁気測定装置、生体磁気測定方法、生体磁気測定装置用センサ筒カバーおよびシート
CA2644429C (en) 2006-03-14 2014-07-29 Lidds Ab Bioresorbable controlled-release composition
US20070258903A1 (en) * 2006-05-02 2007-11-08 Kleiner Lothar W Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
WO2008151193A1 (en) * 2007-06-04 2008-12-11 Biomimetic Therapeutics, Inc. Compositions and methods for treating the vertebral column
US9642891B2 (en) 2006-06-30 2017-05-09 Biomimetic Therapeutics, Llc Compositions and methods for treating rotator cuff injuries
WO2008073628A2 (en) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
DE102006060938A1 (de) * 2006-12-20 2008-06-26 Wolter, Dietmar F., Prof. Dr. Materialdepot zur Abgabe eines antibakteriellen Wirkstoffmaterials
EP2114476A4 (de) * 2007-02-07 2012-12-26 Univ Mcgill Biokeramische implantate mit bioaktiver substanz
EP2014256A1 (de) * 2007-07-12 2009-01-14 Straumann Holding AG Verbundmaterial zur Knochenreparatur
KR100977214B1 (ko) * 2007-10-09 2010-08-24 단국대학교 산학협력단 약물－함입 인산칼슘 복합박막
US20090112315A1 (en) * 2007-10-29 2009-04-30 Zimmer, Inc. Medical implants and methods for delivering biologically active agents
AU2009212151C1 (en) 2008-02-07 2015-09-17 Stryker Corporation Compositions and methods for distraction osteogenesis
WO2009108935A2 (en) * 2008-02-28 2009-09-03 Osteotherapeutics, L.L.C. Method and apparatus for impregnating porous biomaterials with bioactive agents
US20090248162A1 (en) * 2008-03-25 2009-10-01 Warsaw Orthopedic, Inc. Microparticle delivery syringe and needle for placing suspensions and removing vehicle fluid
CA2734254C (en) 2008-08-13 2018-06-05 Smed-Ta/Td, Llc Orthopaedic screws
WO2010019781A1 (en) 2008-08-13 2010-02-18 Smed-Ta/Td, Llc Drug delivery implants
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9358056B2 (en) 2008-08-13 2016-06-07 Smed-Ta/Td, Llc Orthopaedic implant
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
EP2326281A4 (de) * 2008-08-13 2013-05-29 Smed Ta Td Llc Orthopädisches implantat mit porösem strukturelement
CN102149430B (zh) * 2008-09-09 2015-01-14 皇家飞利浦电子股份有限公司 用于沉积能量的治疗系统
MX2011002555A (es) 2008-09-09 2011-08-03 Biomimetic Therapeutics Inc Composiciones de factor de crecimiento derivadas de plaquetas y metodo para el tratamiento de lesiones de tendon y ligamentos.
RU2518528C2 (ru) * 2008-09-09 2014-06-10 Конинклейке Филипс Электроникс Н.В. Терапевтическая система для выделения энергии
AU2010207472B2 (en) 2009-01-23 2015-05-21 Royal College Of Surgeons In Ireland Layered scaffold suitable for osteochondral repair
WO2011103598A1 (en) 2010-02-22 2011-08-25 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
EP2566535A4 (de) * 2010-05-03 2013-12-18 Izhar Halahmi Abgabevorrichtung zur verabreichung eines bioaktiven wirkstoffs
CA2798710C (en) 2010-05-11 2019-08-27 Venkat R. Garigapati Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
US9119887B2 (en) 2010-09-16 2015-09-01 Mo-Sci Corporation Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging
ES2404733B2 (es) * 2011-10-05 2013-09-17 Universidad De Extremadura Andamiaje híbrido bioactivo, método de fabricación y uso para ingeniería de tejido óseo.
WO2013090891A1 (en) * 2011-12-16 2013-06-20 Celanese Eva Performance Polymers, Inc. Controlled release vehicles having desired void volume architectures
KR101973830B1 (ko) 2011-12-21 2019-04-29 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
CN103043635B (zh) * 2012-12-25 2015-04-22 浙江大学 一种抗耐药性的顺铂矿化液及其制备方法和应用
CN105358211B (zh) * 2013-06-05 2018-08-28 皇家飞利浦有限公司 适配器
RU2590859C1 (ru) * 2015-06-30 2016-07-10 государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СибГМУ Минздрава России) Способ дистантной стимуляции регенерации гепатоцитов
CN106268299B (zh) * 2016-08-22 2019-03-29 湖北格林森绿色环保材料股份有限公司 一种微孔介质催化氧化制备空气净化材料的方法及空气净化材料
CN106377983B (zh) * 2016-10-31 2019-02-12 彭伟 一种纳米藻酸钛空气净化材料及其制备方法
CN108066766B (zh) * 2017-12-04 2021-08-31 北京派尔特医疗科技股份有限公司 一种丝材微孔陶瓷层载药方法及系统
RU2770074C1 (ru) * 2021-09-20 2022-04-14 Федеральное государственное бюджетное образовательное учреждение высшего образования «Тамбовский государственный технический университет» (ФГБОУ ВО «ТГТУ») Комбинированный полидисперсный инертный носитель для сушки измельченных растительных материалов

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
JPS55122710A (en) * 1979-02-13 1980-09-20 Kyocera Corp Ceramic small granule for drug administration
JPS59131346A (ja) * 1983-01-17 1984-07-28 日本特殊陶業株式会社 薬液含浸多孔質セラミツクスの製造法
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
JPH01151461A (ja) * 1987-12-08 1989-06-14 Koransha Co Ltd 生体用補綴材料
JP2702953B2 (ja) * 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
JP2842647B2 (ja) * 1988-12-29 1999-01-06 旭光学工業株式会社 薬剤徐放性顆粒及びその製造方法
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
GB9515242D0 (en) * 1995-07-25 1995-09-20 Ecc Int Ltd Porous mineral granules
JPH0987203A (ja) * 1995-09-27 1997-03-31 Kanegafuchi Chem Ind Co Ltd 薬剤含有粒子及びその製造方法
GB2354518B (en) * 1996-10-04 2001-06-13 Dytech Corp Ltd A porous ceramic body composed of bonded particles
EP0975285B1 (de) * 1997-04-01 2008-10-01 CAP Biotechnology, Inc. Kalziumphosphat-mikroträger und -mikrokugeln
US6296667B1 (en) * 1997-10-01 2001-10-02 Phillips-Origen Ceramic Technology, Llc Bone substitutes
JP3400740B2 (ja) * 1999-04-13 2003-04-28 東芝セラミックス株式会社 リン酸カルシウム系多孔質焼結体およびその製造方法
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment

Also Published As

Publication number Publication date
AU7997001A (en) 2002-03-04
WO2002015881A3 (en) 2002-06-27
ES2321479T3 (es) 2009-06-08
CA2420194A1 (en) 2002-02-28
BR0113429A (pt) 2004-04-06
AU2001279970B2 (en) 2006-08-10
CN1469736A (zh) 2004-01-21
DE60137431D1 (de) 2009-03-05
HUP0303111A3 (en) 2007-03-28
WO2002015881A2 (en) 2002-02-28
KR20030040418A (ko) 2003-05-22
JP2004506679A (ja) 2004-03-04
EP1311241B1 (de) 2009-01-14
GB0020610D0 (en) 2000-10-11
RU2283140C2 (ru) 2006-09-10
HUP0303111A2 (hu) 2003-12-29
MXPA03001546A (es) 2004-12-13
US20040265350A1 (en) 2004-12-30
PL361056A1 (pl) 2004-09-20
EP1311241A2 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
ATE420626T1 (de) Verwendung eines porösen trägermaterials
DK0900126T3 (da) Fremstilling af katalysatorbærer
NO20014671D0 (no) Glucokinase-aktivatorer
TR200102384T2 (tr) Implant.
ATE241264T1 (de) Stützvorrichtung zur abgabe von flüchtigen stoffen
DK0764008T3 (da) Ekspanderbart stofimplantat til stabilisering af det spinale segment
ATE411095T1 (de) Keramikfilter und abgasdekontaminierungseinheit
DE60131601D1 (de) Poröses Material
DE69839241D1 (de) Haltevorrichtung zur Herstellung von Präzisionsteilen
DE69909331D1 (de) Intelligenter poröser film oder intelligentes poröses material
DE60029186D1 (de) Keramischer Schaumkörper
EP1338322A4 (de) Mit katalysator ausgerüstetes filter
ATE332673T1 (de) Biologisch funktionalisierte, metabolisch induktive implantatoberflächen
UY26850A1 (es) Activadores de la benzeno acetamida glucoquinasa alfa-acil y alfa-heteroátomo sustituida.
ES2132322T3 (es) Soporte de catalizador y catalizador de polimerizacion de alfa-olefinas; procedimientos para su obtencion y polimerizacion de alfa-olefinas en presencia de catalizador.
AR030833A1 (es) Substrato para procesamiento y/o superficie de soporte
DE59105023D1 (de) Poröser Keramikkörper.
DK81789D0 (da) Fremgangsmaade til konservering af transplanterbare epithellag, som er dyrket in vitro
DE60002113D1 (de) Kohlenstoff-Verbundwerkstoff Kupplungsmaterial mit hoher Dichte und niedriger Porösität
EP1008534A4 (de) Kassettenhalter
DE69928689D1 (de) Haftband für zahnprothese
DE50112406D1 (de) Wundauflage mit verminderter verwachsungstendenz
FR2792348B1 (fr) Materiau absorbant, constitue d'une matiere poreuse a double porosite
DE60115960D1 (de) Absorbierendes produkt
TW200735850A (en) Elastic disposal means

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties